Drug intelligence / Profile preview

ReApt-9

Development stage: Unknown
Lead developer: Pistacia Pharmaceuticals
Administration: Oral

Overview

ReApt-9 is an Ayurvedic proprietary herbal formulation developed and marketed by Pistacia Pharmaceuticals. Formulated as an oral syrup, it is primarily indicated as an appetite stimulant ("The Appetite Maximizer") and for immunity support. The formulation contains a blend of traditional Ayurvedic herbs, including Guduchi (*Tinospora cordifolia*), Saunf (*Foeniculum vulgare*), Kutki (*Picrorhiza kurroa*), Vidang (*Embelia ribes*), Nagarmotha (*Cyperus rotundus*), Jeera (*Cuminum cyminum*), Pippali (*Piper longum*), Amalaki (*Emblica officinalis*), Yavani (*Trachyspermum ammi*), Haritaki (*Terminalia chebula*), and Rohitak (*Tecomella undulata*). These ingredients work synergistically to enhance digestion, stimulate appetite, and support overall immune function.

Brand names: ReApt-9ReApt9ReApt 9
Other names: REAPT 9REAPT9REAPT-9ReApt-9 SyrupReApt9 SyrupReApt 9 Syrup

Beyond the preview

Go deeper on ReApt-9.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReApt-9.